CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a third-quarter loss of $14.4 million, after reporting a profit in the same period a year earlier.

The Cambridge, Massachusetts-based company said it had a loss of 5 cents per share. Losses, adjusted for restructuring costs and non-recurring costs, came to 4 cents per share.

The kidney disease treatment developer posted revenue of $36.9 million in the period.

The company's shares closed at 69 cents. A year ago, they were trading at $2.09.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA